| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Jun 16, 2023 | Lewis Tanya Chief Dev. Op. Officer | Sell | Replimune Group, Inc. | REPL | $24.06 | $309,395 | -8.68% |
| May 16, 2023 | May 19, 2023 | Lewis Tanya Chief Dev. Op. Officer | Sell | Replimune Group, Inc. | REPL | $18.05 | $220,336 | -7.61% |
| May 16, 2022 | May 18, 2022 | Lewis Tanya Chief Dev. Op Officer | Sell | Replimune Group, Inc. | REPL | $14.59 | $79,851 | -4.35% |
| Feb 11, 2021 | Feb 17, 2021 | Lewis Tanya EVP Chief Reg. Affairs | Sell | Karyopharm Therapeutics Inc. | KPTI | $15.52 | $31,752 | -33.06% |
| Oct 30, 2020 | Nov 05, 2020 | Lewis Tanya EVP Chief Reg. Quality Office | Sell | Karyopharm Therapeutics Inc. | KPTI | $15.58 | $3,521 | -29.54% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.